Abstract
Studies on nanotechnology in cancer treatment surpass drug delivery, advancing towards the development of novel therapeutics that can only be achieved through the inherent properties of nanomaterials. In contemporary research and cancer treatment, nanotechnology has emerged as one of the most inventive, quick, and flexible fields. Due to its non-specificity and detrimental effects on normal cells, conventional chemotherapy has limitations and is still a major global health concern. Nanoparticles have become a promising approach for fighting cancer due to their ability to precisely target cancer cells and deliver therapeutic substances to them. Unique characteristics based on dimensions, distribution, and forms are revealed by nanomaterials. The nanoparticles are enhanced anticancer agents due to the coating of phytoconstituents as functional groups to cancer cells for increase the rate of apoptosis. The potential of biosynthesized nanoparticles for cancer treatments is covered in this paper. An effective method with anti-cancer properties, biosynthesized nanoparticles can halt the growth of tumors and cause cancer cells to undergo apoptosis. They could be set up to target particular cancer cells with drugs or other treatments. Notwithstanding its promise, nanoparticles include inconsistent synthesis and characterization, possible toxicity, and effectiveness against different types of cancer.
Get full access to this article
View all access options for this article.